Dose recommendation is 10µg, one-third the dose given to those 12 and older.
Vaccine’s safety studied in 3,100 children age 5–11 and no serious side effects have been detected in the ongoing study. Vaccine was 91% effective in preventing COVID-19 in this age group. FDA grants emergency use authorization for vaccination in children age 5–11.
